Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

BACKGROUND: Gentamicin is used as a therapeutic agent for Ménière’s disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the dose regimen of gentamicin in the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremer, Hendrik G, van Rooy, Ingrid, Pullens, Bas, Colijn, Carla, Stegeman, Inge, van der Zaag-Loonen, Hester J, van Benthem, Peter Paul, Klis, Sjaak F L, Grolman, Wilko, Bruintjes, Tjasse D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141100/
https://www.ncbi.nlm.nih.gov/pubmed/25135244
http://dx.doi.org/10.1186/1745-6215-15-328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141100/
https://www.ncbi.nlm.nih.gov/pubmed/25135244
http://dx.doi.org/10.1186/1745-6215-15-328

Ejemplares similares